{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiagv7y7yadv4yiyts2a6wojzxguagxiwcayecyiuibihdqimg3y4u",
    "uri": "at://did:plc:ox2kiwcr2xmn32p25g472pp7/app.bsky.feed.post/3mmuc73lcoqo2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidki5ge42bjfdv2mfbrtzbrdfrxerpwaadgf53vagaprrrzacwnlm"
    },
    "mimeType": "image/webp",
    "size": 77684
  },
  "path": "/releases/2026/05/260526233632.htm",
  "publishedAt": "2026-05-27T08:49:37.000Z",
  "site": "https://www.sciencedaily.com",
  "textContent": "Scientists at UC San Diego have unveiled a potentially game-changing treatment for MASH, a severe fatty liver disease affecting millions worldwide. The experimental drug, ION224, blocks a liver enzyme that drives fat buildup and inflammation, two key forces behind liver damage. In clinical trials, patients showed striking improvements in liver health, even without losing weight.",
  "title": "New drug could finally stop deadly fatty liver disease"
}